Karyopharm Therapeutics reported $-39640000 in Equity Capital and Reserves for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 810.83M 44.28M
Amgen AMGN:US $ 9334M 75M
AstraZeneca AZN:LN 15676M 1246M
Astrazeneca AZN:US $ 15676M 1246M
Biocryst Pharmaceuticals BCRX:US $ -74.99M 55.73M
Bristol Myers Squibb BMY:US $ 36808M 797M
Eli Lilly And LLY:US $ 6898.7M 1257.1M
Enanta Pharmaceuticals ENTA:US $ 436.03M 15.96M
Epizyme EPZM:US $ 123.03M 61.87M
GlaxoSmithKline GSK:LN 15377M 512M
Karyopharm Therapeutics KPTI:US $ -39640000 90.19M
Macrogenics MGNX:US $ 319.04M 31.49M
Mirati Therapeutics MRTX:US $ 1259.41M 101.38M
Nektar Therapeutics NKTR:US $ 994.51M 82.79M
Novartis NOVN:VX SF 50523M 6075M
Novartis NVS:US $ 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 11977M 951.7M
Sangamo Biosciences SGMO:US $ 470.36M 27.88M
Takeda 4502:JP Y 5299774M 126737M
Tg Therapeutics TGTX:US $ 383.13M 62.16M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M
Xencor XNCR:US $ 583.61M 11.17M
YTE INCY:US $ 2727.84M 116.58M